Insider Transactions

What CRISPR Therapeutics AG's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	7	30
Total trades	15	56

Shares traded

	3 months	12 months
Acquired	182,836	384,020
Disposed	94,308	358,921
Net activity	+88,528	+25,099

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Kulkarni Samarth	Chief Executive Officer	Oct 19	Sale for tax withholding · S	−47,837	$49.78	−$2.38M	311,899
Kulkarni Samarth	Chief Executive Officer	Oct 16	Exercise / conversion · M	+100,000	—	—	359,736
George Simeon	Director	Oct 14	Disclosed 10b5-1 sale · S	−14,514	$49.63	−$720K	15,486
George Simeon	Director	Oct 14	Exercise / conversion · M	+30,000	$14.00	+$420K	30,000
Kasinger James R.	General Counsel and Secretary	Oct 14	Sale for tax withholding · S	−1,040	$49.26	−$51.2K	95,857
Kulkarni Samarth	Chief Executive Officer	Oct 14	Sale for tax withholding · S	−4,098	$49.26	−$202K	259,736
Kasinger James R.	General Counsel and Secretary	Oct 13	Exercise / conversion · M	+2,113	—	—	96,897
Kulkarni Samarth	Chief Executive Officer	Oct 13	Exercise / conversion · M	+8,333	—	—	263,834
Kasinger James R.	General Counsel and Secretary	Oct 06	Disclosed 10b5-1 sale · S	−1,990	$60.04	−$119K	94,784
Kasinger James R.	General Counsel and Secretary	Oct 06	Exercise / conversion · M	+1,990	$13.62	+$27.1K	96,774
Kasinger James R.	General Counsel and Secretary	Sep 22	Disclosed 10b5-1 sale · S	−10,400	$60.24	−$626K	94,784
Kasinger James R.	General Counsel and Secretary	Sep 22	Exercise / conversion · M	+10,400	$13.62	+$142K	105,184
Behbahani Ali	Director	Sep 17	Open-market sale · S	−13,679	$57.09	−$781K	16,637
Behbahani Ali	Director	Sep 17	Exercise / conversion · M	+30,000	$14.00	+$420K	30,316
Prasad Raju	Chief Financial Officer	Aug 07	Gift · G	−750	—	—	14,815
Patel Naimish	Chief Medical Officer	May 29	Sale for tax withholding · S	−3,786	$55.62	−$211K	19,357
Patel Naimish	Chief Medical Officer	May 28	Exercise / conversion · M	+10,000	—	—	23,143
Prasad Raju	Chief Financial Officer	Mar 23	Sale for tax withholding · S	−3,708	$46.78	−$173K	15,565
Kulkarni Samarth	Chief Executive Officer	Mar 23	Sale for tax withholding · S	−10,020	$46.78	−$469K	255,501
Kasinger James R.	General Counsel and Secretary	Mar 23	Sale for tax withholding · S	−3,182	$46.78	−$149K	94,308

Page 1 of 49 · showing the 20 most recent Sign up free to view all 965 transactions and filter by insider →

Comments